Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy

Immunotherapy holds great promise in cancer treatment. The challenges in advancing immunotherapies lie in patient stratification and monitoring therapy. Noninvasive detection of immune checkpoint ligand PD-L1 can serve as an important biomarker for guidance and monitoring of immunotherapy. Here in,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Samit, Lesniak, Wojciech G., Nimmagadda, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676497/
https://www.ncbi.nlm.nih.gov/pubmed/28707500
http://dx.doi.org/10.1177/1536012117718459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676497/
https://www.ncbi.nlm.nih.gov/pubmed/28707500
http://dx.doi.org/10.1177/1536012117718459

Ejemplares similares